Renal stenting heads to MedCAC
This article was originally published in The Gray Sheet
Executive Summary
CMS will convene its Medicare Evidence Development Advisory Committee July 18 to reconsider coverage for renal artery angioplasty and stenting. The agency opened the national coverage decision in February in response to a comparative effectiveness review from the Agency for Healthcare Research & Quality that questions the evidence in support of stenting (1"The Gray Sheet" March 5, 2007, p. 8). AHRQ is updating its review as part of the coverage decision process. The MedCAC meeting extends CMS' decision timeline, with a proposed coverage policy for the procedure expected Nov. 26 and a final decision due Feb. 23...